The global slowdown in economic growth has so far left Roche and Novartis' businesses untouched. Both drug manufacturers, based in Basel, are currently growing significantly faster...
Breast cancer is one of the most common cancer types diagnosed in the world. G1 therapeutics drug trilaciclib may help beat it.